• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-410-3p 和 miR-34c 在鼻咽癌发展和演进中的作用机制。

The mechanism of miR-410-3p and miR-34c in nasopharyngeal carcinoma development and progression.

机构信息

Department of Otorhinolaryngology and Head and Neck Surgery, Chengdu Ren Pin Otorhinolaryngology Hospital, Chengdu, China.

出版信息

Cell Mol Biol (Noisy-le-grand). 2021 Aug 31;67(2):114-120. doi: 10.14715/cmb/2021.67.2.17.

DOI:10.14715/cmb/2021.67.2.17
PMID:34817330
Abstract

To investigate the relationship between miR-410-3p, miR-34c and nasopharyngeal carcinoma development, we detected the expression of miR-410-3p and miR-34c in nasopharyngeal carcinoma tissues and evaluate its clinical value as a molecular marker for predicting the prognosis in patients with nasopharyngeal carcinoma through clinical case study. To identify the role and mechanism of miR-410-3p and miR-34c in nasopharyngeal carcinoma development and progression. The expression of miR-410-3p and miR-34cin 300 cases of nasopharyngeal carcinoma tissues and 30 cases of paired adjacent normal breast tissues was detected by RT-qPCR. The paired t-test was used to compare the differences of miR-410-3pand miR-34c levels between the nasopharyngeal carcinoma and normal groups. The Chi-square test was used to compare the differences between miR-410-3p and miR-34c expression and clinicopathological factors. The Kaplan-Meier survival curve was used to analyze the relationship between miR-410-3p and miR-34c expression and 5-year overall survival (OS). The Cox proportional hazards regression model was used to evaluate the prognostic value. The results were validated by TCGA database. The expression of miR-410-3p was down-regulated in nasopharyngeal carcinoma tissues compared with that of paired normal tissues (P<0.001). The patients with lower miR-410-3p expression have a higher ratio of positive lymph node status (P=0.039) and a poorer 5-year disease-free survival (P=0.001) and 5-year overall survival (P = 0.002). The expression of mi R-34c was down-regulated in nasopharyngeal carcinoma tissues compared with that of paired normal tissues (P<0.001). Up-regulation of the miR-34c inhibited the viability of paired normal tissues (P<0. 01), but there was no significant change in migration of the paired normal tissues. Downregulation of mi R-34c promoted the viability and migration of paired normal tissues (P<0. 05). The expression of miR-410-3p and miR-34c levels are predictors for the OS in patients with nasopharyngeal carcinoma. The expression of miR-410-3p and miR-34c are molecular markers of early nasopharyngeal carcinoma metastasis and an independent prognostic biomarker for patients with nasopharyngeal carcinoma.

摘要

为了研究 miR-410-3p、miR-34c 与鼻咽癌发展之间的关系,我们通过临床病例研究检测了鼻咽癌组织中 miR-410-3p 和 miR-34c 的表达,并评估其作为预测鼻咽癌患者预后的分子标志物的临床价值。为了确定 miR-410-3p 和 miR-34c 在鼻咽癌发展和进展中的作用和机制。通过 RT-qPCR 检测了 300 例鼻咽癌组织和 30 例配对的相邻正常乳腺组织中 miR-410-3p 和 miR-34c 的表达。采用配对 t 检验比较鼻咽癌组和正常组 miR-410-3p 和 miR-34c 水平的差异。采用卡方检验比较 miR-410-3p 和 miR-34c 表达与临床病理因素的差异。采用 Kaplan-Meier 生存曲线分析 miR-410-3p 和 miR-34c 表达与 5 年总生存率(OS)的关系。采用 Cox 比例风险回归模型评估预后价值。通过 TCGA 数据库进行验证。miR-410-3p 在鼻咽癌组织中的表达低于配对正常组织(P<0.001)。miR-410-3p 低表达的患者阳性淋巴结状态的比例更高(P=0.039),5 年无病生存率(P=0.001)和 5 年总生存率(P=0.002)更差。miR-34c 在鼻咽癌组织中的表达低于配对正常组织(P<0.001)。miR-34c 的上调抑制了配对正常组织的活力(P<0.01),但对配对正常组织的迁移没有明显影响。miR-34c 的下调促进了配对正常组织的活力和迁移(P<0.05)。miR-410-3p 和 miR-34c 的表达水平是鼻咽癌患者 OS 的预测因子。miR-410-3p 和 miR-34c 的表达是早期鼻咽癌转移的分子标志物,也是鼻咽癌患者独立的预后生物标志物。

相似文献

1
The mechanism of miR-410-3p and miR-34c in nasopharyngeal carcinoma development and progression.miR-410-3p 和 miR-34c 在鼻咽癌发展和演进中的作用机制。
Cell Mol Biol (Noisy-le-grand). 2021 Aug 31;67(2):114-120. doi: 10.14715/cmb/2021.67.2.17.
2
microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.microRNA-342-3p 通过靶向 FOXQ1 抑制鼻咽癌细胞的侵袭表型。
BMC Cancer. 2019 Jan 24;19(1):104. doi: 10.1186/s12885-018-5225-5.
3
FOXD1, negatively regulated by miR-186, promotes the proliferation, metastasis and radioresistance of nasopharyngeal carcinoma cells.叉头框蛋白 D1(FOXD1)受 miR-186 负调控,促进鼻咽癌细胞的增殖、转移和放射抵抗。
Cancer Biomark. 2020;28(4):511-521. doi: 10.3233/CBM-191311.
4
Up-regulation of miR-34c-5p inhibits nasopharyngeal carcinoma cells by mediating NOTCH1.miR-34c-5p 的上调通过调控 NOTCH1 抑制鼻咽癌细胞。
Biosci Rep. 2020 Jun 26;40(6). doi: 10.1042/BSR20200302.
5
MicroRNA-494-3p Promotes Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Targeting Sox7.微小RNA-494-3p通过靶向Sox7促进鼻咽癌细胞的生长、迁移和侵袭。
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818809993. doi: 10.1177/1533033818809993.
6
MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.miR-34c 通过靶向 MET 抑制鼻咽癌的肿瘤生长和转移。
Cell Death Dis. 2015 Jan 22;6(1):e1618. doi: 10.1038/cddis.2014.582.
7
Long non-coding RNA CASC15 promotes nasopharyngeal carcinoma cell proliferation and metastasis by downregulating miR-101-3p.长链非编码 RNA CASC15 通过下调 miR-101-3p 促进鼻咽癌细胞的增殖和转移。
Eur Rev Med Pharmacol Sci. 2019 Oct;23(20):8897-8904. doi: 10.26355/eurrev_201910_19285.
8
miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN.miR-144-3p 通过与 PTEN 的相互作用促进鼻咽癌的发生。
J Cell Physiol. 2019 Aug;234(10):17912-17924. doi: 10.1002/jcp.28424. Epub 2019 Mar 4.
9
MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.miR-34c 下调导致鼻咽癌细胞中 SOX4 过表达和顺铂耐药。
BMC Cancer. 2020 Jun 26;20(1):597. doi: 10.1186/s12885-020-07081-z.
10
MiR-1178-3p promotes the proliferation, migration and invasion of nasopharyngeal carcinoma Sune-1 cells by targeting STK4.miR-1178-3p 通过靶向 STK4 促进鼻咽癌细胞 Sune-1 的增殖、迁移和侵袭。
J Biol Regul Homeost Agents. 2019 Mar-Apr;33(2):321-330.

引用本文的文献

1
MiRNA signatures in nasopharyngeal carcinoma: molecular mechanisms and therapeutic perspectives.鼻咽癌中的微小RNA特征:分子机制与治疗前景
Am J Cancer Res. 2023 Dec 15;13(12):5805-5824. eCollection 2023.